文献速递疼痛医学

多中心研究评估腰痛注射治疗结局相关因素

Multicenter study evaluating factors associated with treatment outcome for low back pain injections.
PubMed 文献 · Reg Anesth Pain Med · 2021-12-08

该前瞻性多中心研究纳入346例患者,评估硬膜外类固醇注射、骶髂关节注射和椎间关节干预的结局预测因素。所有组疼痛评分均下降(平均1.8±2.6,p<0.0001),组间无差异。较低基线疼痛、抑郁症状和肥胖与较小疼痛改善相关;抑郁和较差基线功能与治疗失败相关。

要点

  • 所有注射组疼痛均下降,组间无差异
  • 抑郁症状和肥胖与较小疼痛改善相关
  • 抑郁和较差基线功能与治疗失败相关

核心结论

  • 疾病负担较重、抑郁和肥胖患者更可能治疗失败,应在操作前或同时考虑处理这些因素。

研究设计与样本

  • 前瞻性多中心研究,纳入346例患者,评估硬膜外类固醇注射、骶髂关节注射和椎间关节干预的结局预测因素。

主要发现

  • 所有组平均NRS-PI下降(p<0.0001;平均1.8±2.6),组间变化无差异(p=0.50)。
  • 较低基线疼痛评分(校正系数-0.32,95%CI -0.48至-0.16,p<0.0001)、抑郁症状(校正系数0.076,95%CI 0.039至0.113,p<0.0001)和肥胖(校正系数0.62,95%CI 0.038至1.21,p=0.037)与较小疼痛改善相关。
  • 抑郁(校正OR 0.94,95%CI 0.91至0.97,p<0.0001)和较差基线功能(校正OR 0.59,95%CI 0.36至0.96,p=0.034)与治疗失败相关。
  • 吸烟、睡眠功能障碍和非器质性体征在单变量分析中与负面结局相关,但在多变量分析中不显著。

临床怎么用

  • 对于疾病负担较重、抑郁或肥胖的腰痛患者,应在注射治疗前或同时考虑处理这些因素以改善结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There has been a worldwide surge in interventional procedures for low back pain (LBP), with studies yielding mixed results. These data support the need for identifying outcome predictors based on unique characteristics in a pragmatic setting. METHODS: We prospectively evaluated the association between over two dozen demographic, clinical and technical factors on treatment outcomes for three procedures: epidural steroid injections (ESIs) for sciatica, and sacroiliac joint (SIJ) injections and facet interventions for axial LBP. The primary outcome was change in patient-reported average pain intensity on a numerical rating scale (average NRS-PI) using linear regression. For SIJ injections and facet radiofrequency ablation, this was average LBP score at 1 and 3 months postprocedure, respectively. For ESI, it was average leg pain 1- month postinjection. Secondary outcomes included a binary indicator of treatment response (success). RESULTS: 346 patients were enrolled at seven hospitals. All groups experienced a decrease in average NRS-PI (p<0.0001; mean 1.8±2.6). There were no differences in change in average NRS-PI among procedural groups (p=0.50). Lower baseline pain score (adjusted coefficient -0.32, 95% CI -0.48 to -0.16, p<0.0001), depressive symptomatology (adjusted coefficient 0.076, 95% CI 0.039 to 0.113, p<0.0001) and obesity (adjusted coefficient 0.62, 95% CI 0.038 to 1.21, p=0.037) were associated with smaller pain reductions. For procedural outcome, depression (adjusted OR 0.94, 95% CI 0.91, 0.97, p<0.0001) and poorer baseline function (adjusted OR 0.59, 95% CI 0.36, 0.96, p=0.034) were associated with failure. Smoking, sleep dysfunction and non-organic signs were associated with negative outcomes in univariate but not multivariate analyses. CONCLUSIONS: Identifying treatment responders is a critical endeavor for the viability of procedures in LBP. Patients with greater disease burden, depression and obesity are more likely to fail interventions. Steps to address these should be considered before or concurrent with procedures as considerations dictate. TRIAL REGISTRATION NUMBER: NCT02329951.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Cohen SP, Doshi TL, Kurihara C, et al. Multicenter study evaluating factors associated with treatment outcome for low back pain injections. Reg Anesth Pain Med. 2021. PMID: 34880117. doi:10.1136/rapm-2021-103247

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。